AstraZeneca: Public relations nightmare around vaccine may lead to vaccine hesitancy - researchers

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
A health worker holds up a AstraZeneca vaccine at the Ridge Hospital in Accra, Ghana, on March 2.
A health worker holds up a AstraZeneca vaccine at the Ridge Hospital in Accra, Ghana, on March 2.
Nipah Dennis/AFP via Getty Images

The story: The public scrutiny and public relations nightmare around the AstraZeneca vaccine might lead to vaccine hesitancy, researchers warn. 

The context: The vaccine has had to weather one controversy after another since the worldwide rollout began. In South Africa, the rollout was halted after the vaccine was found not to be efficacious against the 501Y.V2 variant currently circulating in the country. 

Elsewhere in the world: Last week, the vaccine was paused in a few European countries following fears it might cause blood clots in people who receive the jab. 

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
Lockdown For
DAYS
HRS
MINS
Voting Booth
As a child or as an adult, have you ever been a victim of bullying?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, at school
55% - 2625 votes
Yes, at work
17% - 818 votes
No, I've never experienced this
28% - 1317 votes
Vote
USD/ZAR
14.29
(-0.0)
GBP/ZAR
19.97
(+0.4)
EUR/ZAR
17.22
(+0.6)
AUD/ZAR
11.10
(+0.6)
JPY/ZAR
0.13
(+0.2)
Gold
1,774.76
(+0.2)
Silver
25.94
(+0.5)
Platinum
1,193.00
(-1.4)
Brent Crude
67.05
(+0.4)
Palladium
2,763.00
(-1.9)
All Share
67,584
(-0.8)
Top 40
61,844
(-0.8)
Financial 15
12,268
(-1.2)
Industrial 25
87,836
(-0.5)
Resource 10
69,152
(-0.9)
All JSE data delayed by at least 15 minutes Iress logo